PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.
BMJ
; 377: e069116, 2022 05 04.
Article
in En
| MEDLINE
| ID: mdl-35508321
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cardiovascular Diseases
/
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Stroke
/
Anticholesteremic Agents
/
Myocardial Infarction
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Adult
/
Humans
Language:
En
Journal:
BMJ
Journal subject:
MEDICINA
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom